mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
TAE684 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.2 |
mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
Methotrexate |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.2 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.037 |
0.2 |